Browse > Article
http://dx.doi.org/10.1016/j.jgr.2017.01.003

Efficacy and safety of Panax ginseng berry extract on glycemic control: A 12-wk randomized, double-blind, and placebo-controlled clinical trial  

Choi, Han Seok (Division of Endocrinology and Metabolism, Department of Internal Medicine, Dongguk University Ilsan Hospital)
Kim, Sunmi (Research and Development Center, Amorepacific Corporation)
Kim, Min Jung (Nutrition and Metabolism Research Group, Korea Food Research Institute)
Kim, Myung-Sunny (Nutrition and Metabolism Research Group, Korea Food Research Institute)
Kim, Juewon (Research and Development Center, Amorepacific Corporation)
Park, Chan-Woong (Research and Development Center, Amorepacific Corporation)
Seo, Daebang (Research and Development Center, Amorepacific Corporation)
Shin, Song Seok (Research and Development Center, Amorepacific Corporation)
Oh, Sang Woo (Department of Family Medicine, Dongguk University Ilsan Hospital)
Publication Information
Journal of Ginseng Research / v.42, no.1, 2018 , pp. 90-97 More about this Journal
Abstract
Background: Antihyperglycemic effects of Panax ginseng berry have never been explored in humans. The aims of this study were to assess the efficacy and safety of a 12-wk treatment with ginseng berry extract in participants with a fasting glucose level between 100 mg/dL and 140 mg/dL. Methods: This study was a 12-wk, randomized, double-blind, placebo-controlled clinical trial. A total of 72 participants were randomly allocated to two groups of either ginseng berry extract or placebo, and 63 participants completed the study. The parameters related to glucose metabolism were assessed. Results: Although the present study failed to show significant antihyperglycemic effects of ginseng berry extract on the parameters related to blood glucose and lipid metabolism in the total study population, it demonstrated that ginseng berry extract could significantly decrease serum concentration of fasting glucose by 3.7% (p = 0.035), postprandial glucose at 60 min during 75 g oral glucose tolerance test by 10.7% (p = 0.006), and the area under the curve for glucose by 7.7% (p = 0.024) in those with fasting glucose level of 110 mg/dL or higher, while the placebo group did not exhibit a statistically significant decrease. Safety profiles were not different between the two groups. Conclusion: The present study suggests that ginseng berry extract has the potential to improve glucose metabolism in human, especially in those with fasting glucose level of 110 mg/dL or higher. For a more meaningful benefit, further research in people with higher blood glucose levels is required.
Keywords
antihyperglycemic effects; clinical trial; glucose metabolism; oral glucose tolerance test; Panax ginseng berry;
Citations & Related Records
Times Cited By KSCI : 6  (Citation Analysis)
연도 인용수 순위
1 American Diabetes Association and National Institute of Diabetes. Digestive and Kidney Diseases. The prevention or delay of type 2 diabetes. Diabetes Care 2002;25:742-9.   DOI
2 Bi X, Xia X, Mou T, Jiang B, Fan D, Wang P, Liu Y, Hou Y, Zhao Y. Anti-tumor activity of three ginsenoside derivatives in lung cancer is associated with Wnt/${\beta}$-catenin signaling inhibition. Eur J Pharmacol 2014;742:145-52.   DOI
3 Ramesh T, Kim SW, Sung JH, Hwang SY, Sohn SH, Yoo SK, Kim SK. Effect of fermented Panax ginseng extract (GINST) on oxidative stress and antioxidant activities in major organs of aged rats. Exp Gerontol 2012;47:77-84.   DOI
4 Hong CE, Lyu SY. Anti-inflammatory and anti-oxidative effects of Korean Red Ginseng extract in human keratinocytes. Immune Netw 2011;11:42-9.   DOI
5 Jung JW, Kang HR, Ji GE, Park MS, Song WJ, Kim MH, Kwon JW, Kim TW, Park HW, Cho SH, Min KU. Therapeutic effects of fermented red ginseng in allergic rhinitis: a randomized, double-blind, placebo-controlled study. Allergy Asthma Immunol Res 2011;3:103-10.   DOI
6 Kim K, Kim HY. Korean Red Ginseng stimulates insulin release from isolated rat pancreatic islets. J Ethnopharmacol 2008;120:190-5.   DOI
7 Kim JJ, Xiao H, Tan Y, Wang ZZ, Paul Seale J, Qu X. The effects and mechanism of saponins of Panax notoginseng on glucose metabolism in 3T3-L1 cells. Am J Chin Med 2009;37:1179-89.   DOI
8 Kimura M, Waki I, Chujo T, Kikuchi T, Hiyama C, Yamazaki K, Tanaka O. Effects of hypoglycemic components in ginseng radix on blood insulin level in alloxan diabetic mice and on insulin release from perfused rat pancreas. J Pharm Dyn 1981;4:410-7.   DOI
9 Yokozawa T, Kobayashi T, Oura H, Kawashima Y. Studies on the mechanism of the hypoglycemic activity of ginsenoside-Rb2 in straptozotocin-diabetic rats. Chem Pharm Bull 1985;33:869-72.   DOI
10 Ceriello A, Ihnat M. "Glycaemic variability:" a new therapeutic challenge in diabetes and the critical care setting. Diabet Med 2010;27:862-7.   DOI
11 Cavalot F, Petrelli A, Traversa M, Bonomo K, Fiora E, Conti M, Anfossi G, Costa G, Trovati M. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocrinol Metab 2006;91:813-9.   DOI
12 Yun SN, Moon SJ, Ko SK, Im BO, Chung SH. Wild ginseng prevents the onset of high-fat diet induced hyperglycemia and obesity in ICR mice. Arch Pharm Res 2004;27:790-6.   DOI
13 Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOPNIDDM trial. JAMA 2003;290:486-94.   DOI
14 Hanefeld M, Cagatay M, Petrowitsch T, Neuser D, Petzinna D, Rupp M. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J 2004;25:10-6.   DOI
15 Jung HS. Clinical implications of glucose variability: chronic complications of diabetes. Endocrinol Metab 2015;30:167-74.   DOI
16 Kimura I, Nakashima N, Sugihara Y, Fu-jun C, Kimura M. The antihyperglycaemic blend effect of traditional Chinese medicine byakko-ka-ninjinto on alloxan and diabetic KK-CA(y) mice. Phytother Res 1999;13:484-8.   DOI
17 Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L, Dey L, Pugh W, Rue PA, Polonsky KS, Yuan CS. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002;51:1851-8.   DOI
18 Xie JT, Zhou YP, Dey L, Attele AS, Wu JA, Gu M, Polonsky KS, Yuan CS. Ginseng berry reduces blood glucose and body weight in db/db mice. Phytomedicine 2002;9:254-8.   DOI
19 Yuan HD, Kin SJ, Quan HY, Huang B, Chung SH. Ginseng leaf extract prevents high fat diet-induced hyperglycemia and hyperlipidemia through AMPK activation. J Ginseng Res 2010;34:369-75.   DOI
20 Yuan HD, Shin EJ, Chung SH. Anti-diabetic effect and mechanism of Korean red ginseng in C57BL/KsJ db/db mice. J Ginseng Res 2008;32:187-93.   DOI
21 Vuksan V, Sievenpiper JL, Koo VYY, Francis T, Beljan-Zdravkovic U, Xu Z, Vidgen E. American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus. Arch Intern Med 2000;160:1009-13.   DOI
22 Lee HJ, Lee YH, Park SK, Kang ES, Kim HJ, Lee YC, Choi CS, Park SE, Ahn CW, Cha BS, et al. Korean Red Ginseng (Panax ginseng) improves insulin sensitivity and attenuates the development of diabetes in Otsuka LongeEvans Tokushima fatty rats. Metabolism 2009;58:1170-7.   DOI
23 Liu Z, Wang LJ, Li X, Hu JN, Chen Y, Ruan CC, Sun GZ. Hypoglycemic effects of malonyl-ginsenosides extracted from roots of Panax ginseng on streptozotocin-induced diabetic mice. Phytother Res 2009;23:1426-30.   DOI
24 Sotaniemi EA, Haapakoski E, Rautio A. Ginseng therapy in non-insulin dependent diabetic patients. Diabetes Care 1995;18:1373-5.   DOI
25 Vuksan V, Sung MK, Sievenpiper JL, Stavro PM, Jenkins AL, Di Buono M, Lee KS, Leiter LA, Nam KY, Arnason JT, et al. Korean Red Ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebocontrolled study of efficacy and safety. Nutr Metab Cardiovasc Dis 2008;18:46-56.   DOI
26 Dey L, Xie JT, Wang A, Wu J, Maleckar SA, Yuan CS. Anti-hyperglycemic effects of ginseng: comparison between root and berry. Phytomedicine 2003;10: 600-5.   DOI
27 Kim YK, Yoo DS, Xu H, Park NI, Kim HH, Choi JE, Park SU. Ginsenoside content of berries and roots of three typical Korean ginseng (Panax ginseng) cultivars. Nat Prod Commun 2009;4:903-6.
28 Kim CK, Cho DH, Lee KS, Lee DK, Park CW, Kim WG, Lee SJ, Ha KS, Taeg OG, Kwon YG, et al. Ginseng berry extract prevents atherogenesis via antiinflammatory action by upregulating phase II gene expression. Evid Based Complement Alternat Med 2012;2012:490301.
29 Ji QC, Harkey MR, Henderson GL, Gershwin ME, Stern JS, Hackman RM. Quantitative determination of ginsenosides by high-performance liquid chromatography-tandem mass spectrometry. Phytochem Anal 2001;12: 320-6.   DOI
30 Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999;58:1685-93.   DOI
31 Xie JT, Mehendale SR, Li X, Quigg R, Wang X, Wang CZ, Wu JA, Aung HH, A Rue P, Bell GI, et al. Anti-diabetic effect of ginsenoside Re in ob/ob mice. Biochim Biophys Acta 2005;1740:319-25.   DOI
32 Ma SW, Benzie IF, Chu TT, Fok BS, Tomlinson B, Critchley LA. Effect of Panax ginseng supplementation on biomarkers of glucose tolerance, antioxidant status and oxidative stress in type 2 diabetic subjects: results of a placebocontrolled human intervention trial. Diabetes Obes Metab 2008;10:1125-7.   DOI
33 Reay JL, Scholey AB, Milne A, Fenwick J, Kennedy DO. Panax ginseng has no effect on indices of glucose regulation following acute or chronic ingestion in healthy volunteers. Br J Nutr 2009;101:1673-8.   DOI
34 Reeds DN, Patterson BW, Okunade A, Holloszy JO, Polonsky KS, Klein S. Ginseng and ginsenoside Re do not improve ${\beta}$-cell function or insulin sensitivity in overweight and obese subjects with impaired glucose tolerance or diabetes. Diabetes Care 2011;34:1071-6.   DOI
35 Oh MR, Park SH, Kim SY, Back HI, Kim MG, Jeon JY, Ha KC, Na WT, Cha YS, Park BH, Park TS, Chae SW. Postprandial glucose-lowering effects of fermented red ginseng in subjects with impaired fasting glucose or type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial. BMC Complement Altern Med 2014;14:237.   DOI
36 Seo E, Kim S, Lee SJ, Oh BC, Jun HS. Ginseng berry extract supplementation improves age-related decline of insulin signaling in mice. Nutrients 2015;7: 3038-53.   DOI
37 Bang H, Kwak JH, Ahn HY, Shin DY, Lee JH. Korean red ginseng improves glucose control in subjectswith impaired fasting glucose, impaired glucose tolerance, or newly diagnosed type 2 diabetes mellitus. J Med Food 2014;17:128-34.   DOI
38 Yuan HD, Kim JT, Kim SH, Chung SH. Ginseng and diabetes: the evidences from in vitro, animal and human studies. J Ginseng Res 2012;36:27-39.   DOI
39 Park EY, Kim HJ, Kim YK, Park SU, Choi JE, Cha JY, Jun HS. Increase in insulin secretion induced by Panax ginseng berry extracts contributes to the amelioration of hyperglycemia in streptozotocin-induced diabetic mice. J Ginseng Res 2012;36:153-60.   DOI
40 Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14.   DOI
41 Ha KH, Kim DJ. Trends in the diabetes epidemics in Korea. Endocrinol Metab 2015;30:142-6.   DOI